Key result
A newly discovered aryl ether series derived from diphenymethyl amides acts as a potent and selective Nav1.3 inhibitor with good oral pharmacokinetics.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
An aryl ether series of potent and selective Na v 1.3 inhibitors is described, starting from a series of diphenymethyl amides.
No takes yet. Share an insight, caveat, or question.
Pryde et al. (2017) studied this question. A newly discovered aryl ether series derived from diphenymethyl amides acts as a potent and selective Nav1.3 inhibitor with good oral pharmacokinetics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: